Details for New Drug Application (NDA): 090263
✉ Email this page to a colleague
The generic ingredient in LEVETIRACETAM is levetiracetam. There are thirty-five drug master file entries for this compound. Eighty-six suppliers are listed for this compound. Additional details are available on the levetiracetam profile page.
Summary for 090263
Tradename: | LEVETIRACETAM |
Applicant: | Chartwell Molecular |
Ingredient: | levetiracetam |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 090263
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 090263
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LEVETIRACETAM | levetiracetam | SOLUTION;ORAL | 090263 | ANDA | Chartwell RX, LLC | 62135-548 | 62135-548-24 | 2 TRAY in 1 BOX (62135-548-24) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (62135-548-45) |
LEVETIRACETAM | levetiracetam | SOLUTION;ORAL | 090263 | ANDA | Chartwell RX, LLC | 62135-548 | 62135-548-47 | 473 mL in 1 BOTTLE (62135-548-47) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;ORAL | Strength | 100MG/ML | ||||
Approval Date: | Apr 3, 2009 | TE: | AA | RLD: | No |
Complete Access Available with Subscription